ID   CEPT1_RAT               Reviewed;         416 AA.
AC   Q6AXM5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   02-OCT-2024, entry version 128.
DE   RecName: Full=Choline/ethanolaminephosphotransferase 1 {ECO:0000305};
DE            EC=2.7.8.1 {ECO:0000250|UniProtKB:Q9Y6K0};
DE            EC=2.7.8.2 {ECO:0000250|UniProtKB:Q9Y6K0};
DE   AltName: Full=1-alkenyl-2-acylglycerol choline phosphotransferase {ECO:0000305};
DE            EC=2.7.8.22 {ECO:0000250|UniProtKB:Q9Y6K0};
GN   Name=Cept1 {ECO:0000312|RGD:1359727};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes both phosphatidylcholine and
CC       phosphatidylethanolamine biosynthesis from CDP-choline and CDP-
CC       ethanolamine, respectively. Involved in protein-dependent process of
CC       phospholipid transport to distribute phosphatidyl choline to the
CC       lumenal surface. Has a higher cholinephosphotransferase activity than
CC       ethanolaminephosphotransferase activity.
CC       {ECO:0000250|UniProtKB:Q9Y6K0}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + CDP-ethanolamine = a 1,2-diacyl-sn-
CC         glycero-3-phosphoethanolamine + CMP + H(+); Xref=Rhea:RHEA:32943,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:57876,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:64612; EC=2.7.8.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32944;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + CDP-choline = a 1,2-diacyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:32939,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:57643,
CC         ChEBI:CHEBI:58779, ChEBI:CHEBI:60377; EC=2.7.8.2;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32940;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-2-acyl-sn-glycerol + CDP-choline = 1-O-alkyl-2-acyl-
CC         sn-glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:36179,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:36702, ChEBI:CHEBI:52595,
CC         ChEBI:CHEBI:58779, ChEBI:CHEBI:60377; EC=2.7.8.2;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36180;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z-alkenyl)-2-acyl-sn-glycerol + CDP-choline = 1-O-(1Z-
CC         alkenyl)-2-acyl-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:36227, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:77286, ChEBI:CHEBI:77296; EC=2.7.8.22;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36228;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dioctanoyl-sn-glycerol + CDP-choline = 1,2-dioctanoyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:54232,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58779, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:76979, ChEBI:CHEBI:78228;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54233;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-didecanoyl-sn-glycerol + CDP-choline = 1,2-didecanoyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:54236,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:18155, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:78226;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54237;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + CDP-choline = 1,2-di-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:54240, ChEBI:CHEBI:15378, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:58779, ChEBI:CHEBI:60377, ChEBI:CHEBI:74669;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54241;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + CDP-choline =
CC         1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + CMP
CC         + H(+); Xref=Rhea:RHEA:54244, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:73001, ChEBI:CHEBI:75466;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54245;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + CDP-ethanolamine = 1,2-
CC         di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine + CMP + H(+);
CC         Xref=Rhea:RHEA:54248, ChEBI:CHEBI:15378, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:57876, ChEBI:CHEBI:60377, ChEBI:CHEBI:74986;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54249;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + CDP-
CC         ethanolamine = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine + CMP + H(+); Xref=Rhea:RHEA:54252,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57876, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:73007, ChEBI:CHEBI:75466;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54253;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycerol + CDP-choline = 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
CC         docosahexaenoyl)-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:54332, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:74963, ChEBI:CHEBI:82949;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54333;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-hexadecenoyl)-sn-glycerol + CDP-choline = 1,2-di-
CC         (9Z-hexadecenoyl)-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:54336, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:83717, ChEBI:CHEBI:84417;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54337;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-hexadecenoyl)-sn-glycerol + CDP-ethanolamine = 1,2-
CC         di-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine + CMP + H(+);
CC         Xref=Rhea:RHEA:54340, ChEBI:CHEBI:15378, ChEBI:CHEBI:57876,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:84417, ChEBI:CHEBI:138145;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54341;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-acetyl-sn-glycerol + CDP-choline = 1-O-
CC         hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:54348, ChEBI:CHEBI:15378, ChEBI:CHEBI:44811,
CC         ChEBI:CHEBI:58779, ChEBI:CHEBI:60377, ChEBI:CHEBI:75936;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54349;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol +
CC         CDP-choline = 1-O-hexadecyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:54352,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:55430, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:77184;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54353;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6K0};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylethanolamine
CC       biosynthesis; phosphatidylethanolamine from ethanolamine: step 3/3.
CC       {ECO:0000250|UniProtKB:Q9Y6K0}.
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis;
CC       phosphatidylcholine from phosphocholine: step 2/2.
CC       {ECO:0000250|UniProtKB:Q9Y6K0}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9Y6K0}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9Y6K0}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9Y6K0}. Nucleus membrane
CC       {ECO:0000250|UniProtKB:Q9Y6K0}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9Y6K0}.
CC   -!- SIMILARITY: Belongs to the CDP-alcohol phosphatidyltransferase class-I
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC079471; AAH79471.1; -; mRNA.
DR   RefSeq; NP_001007700.1; NM_001007699.1.
DR   RefSeq; XP_006233178.1; XM_006233116.3.
DR   RefSeq; XP_006233180.1; XM_006233118.3.
DR   RefSeq; XP_017446413.1; XM_017590924.1.
DR   AlphaFoldDB; Q6AXM5; -.
DR   SMR; Q6AXM5; -.
DR   STRING; 10116.ENSRNOP00000032597; -.
DR   GlyCosmos; Q6AXM5; 1 site, No reported glycans.
DR   GlyGen; Q6AXM5; 1 site.
DR   PhosphoSitePlus; Q6AXM5; -.
DR   PaxDb; 10116-ENSRNOP00000032597; -.
DR   Ensembl; ENSRNOT00000036551.5; ENSRNOP00000032597.3; ENSRNOG00000017723.6.
DR   Ensembl; ENSRNOT00055033582; ENSRNOP00055027233; ENSRNOG00055019690.
DR   Ensembl; ENSRNOT00060050693; ENSRNOP00060042169; ENSRNOG00060029203.
DR   Ensembl; ENSRNOT00065039032; ENSRNOP00065031688; ENSRNOG00065022850.
DR   GeneID; 310773; -.
DR   KEGG; rno:310773; -.
DR   UCSC; RGD:1359727; rat.
DR   AGR; RGD:1359727; -.
DR   CTD; 10390; -.
DR   RGD; 1359727; Cept1.
DR   eggNOG; KOG2877; Eukaryota.
DR   GeneTree; ENSGT00950000183117; -.
DR   HOGENOM; CLU_035066_1_0_1; -.
DR   InParanoid; Q6AXM5; -.
DR   OrthoDB; 5482983at2759; -.
DR   PhylomeDB; Q6AXM5; -.
DR   TreeFam; TF313270; -.
DR   Reactome; R-RNO-1483191; Synthesis of PC.
DR   Reactome; R-RNO-1483213; Synthesis of PE.
DR   UniPathway; UPA00558; UER00743.
DR   UniPathway; UPA00753; UER00740.
DR   PRO; PR:Q6AXM5; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000017723; Expressed in liver and 20 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0047359; F:1-alkenyl-2-acylglycerol choline phosphotransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004142; F:diacylglycerol cholinephosphotransferase activity; IBA:GO_Central.
DR   GO; GO:0004307; F:ethanolaminephosphotransferase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; ISO:RGD.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; ISO:RGD.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; IBA:GO_Central.
DR   Gene3D; 1.20.120.1760; -; 1.
DR   InterPro; IPR000462; CDP-OH_P_trans.
DR   InterPro; IPR043130; CDP-OH_PTrfase_TM_dom.
DR   InterPro; IPR048254; CDP_ALCOHOL_P_TRANSF_CS.
DR   InterPro; IPR014472; CHOPT.
DR   PANTHER; PTHR10414:SF27; CHOLINE_ETHANOLAMINEPHOSPHOTRANSFERASE 1; 1.
DR   PANTHER; PTHR10414; ETHANOLAMINEPHOSPHOTRANSFERASE; 1.
DR   Pfam; PF01066; CDP-OH_P_transf; 1.
DR   PIRSF; PIRSF015665; CHOPT; 1.
DR   PROSITE; PS00379; CDP_ALCOHOL_P_TRANSF; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Glycoprotein; Lipid biosynthesis; Lipid metabolism;
KW   Magnesium; Manganese; Membrane; Metal-binding; Nucleus;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Phosphoprotein;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..416
FT                   /note="Choline/ethanolaminephosphotransferase 1"
FT                   /id="PRO_0000289247"
FT   TRANSMEM        89..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        116..133
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        156..176
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        180..199
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        210..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        246..267
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        286..306
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        315..334
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        349..363
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   TRANSMEM        368..388
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..15
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        155
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         86
FT                   /ligand="CDP-choline"
FT                   /ligand_id="ChEBI:CHEBI:58779"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         133
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         133
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         151
FT                   /ligand="CDP-choline"
FT                   /ligand_id="ChEBI:CHEBI:58779"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         154
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         154
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   BINDING         158
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   SITE            151
FT                   /note="Increases basicity of active site His"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   MOD_RES         40
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6K0"
FT   CARBOHYD        144
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   416 AA;  46498 MW;  13C6E63AADC8D76B CRC64;
     MSGHRSTRKR CGDSHPESPV GFGHMSTTGC ILNKLFQLPT PPLSRHQLKR LEEHRYQSAG
     RSLLEPLMQG YWEWLVGRVP SWIAPNLITI IGLSINICTT ILLVFYCPTA TEQAPLWAYI
     ACACGLFIYQ SLDAIDGKQA RRTNSSSPLG ELFDHGCDSL STVFVVLGTC IAVQLGTNPD
     WMFFCCFAGT FMFYCAHWQT YVSGTLRFGI IDVTEVQIFI IIMHLLAVIG GPPFWQSMIP
     VLNIQMKLFP ALCTVAGTIF SCTNYFRVIF TGGVGKNGST IAGTSVLSPF LHIGSVITLA
     VMIYKKSAVQ LFEKHPCLYI LTFGFVSAKI TNKLVVAHMT KSEMHLHDTA FIGPALLFLD
     QYFNSFIDEY IVLWIALVFS FFDLIRYCVS VCNQIASHLH IHVFRIKTST AHSNHH
//
